Association of eosinophil levels with 30-day overall mortality in hospitalized patients with aspiration pneumonia
Authors:
Open Access
- 16 June 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Aspiration pneumonia (AP) is expected to have an increasing contribution to morbidity and mortality, particularly in the elderly population over the next coming decades. However, there are no reliable disease evaluation methods and prognostic indicators for patients with AP. A total of 841 patients with AP were included in this single-center prospective cohort study, among which 406 patients were in the eosinopenia group (an absolute eosinophil count < 0.05 × 109/L), and 435 patients were in the non-eosinopenia group (an absolute eosinophil count ≥ 0.05 × 109/L). The primary outcome measure was 30-day overall mortality. The Cox proportional-hazards regression models with overlap weighting according to the propensity score were employed to estimate the associations between eosinopenia level and 30-day overall mortality. 841 AP patients (406 in eosinopenia, 435 in non-eosinopenia), mean ages (75.15 ± 16.76 years in eosinopenia, 78.23 ± 15.28 years in non-eosinopenia), 71 deaths within 30 days (62 in eosinopenia, 9 in non-eosinopenia), 30-day death rates were 15.27% in eosinopenia and 2.07% in non-eosinopenia), 30-day overall mortality hazard ratio by multivariate Cox regression (HR 3.884. for eosinopenia vs. non-eosinopenia, 95% CI 1.772-8.514), after propensity score weighting-overlap weighting (HR 2.337, 95% CI 1.052-5.194), sensitivity analyses ratio (HR 2.951, 95% CI 1.163-7.484) by propensity score matching and (HR 2.574, 95% CI 1.143-5.796) by propensity score regression. The Aspiration Pneumonia Patients with Low Eosinophil counts (APPLE) prospective cohort study suggested that eosinopenia in patients with AP was associated with an increased risk of 30-day overall mortality.Trial registration: Chinese Clinical Trial Registry. URL https://www.chictr.org.cn/. Registration number ChiCTR2300076254. Registration date September 28, 2023.Keywords
Funding Information
- Shanxi Province’s Special Project for Guiding the Transformation and Application of Scientific and Technological Achie (202404021301059)
- the Scientific Research Project of Shanxi Provincial Health Commission (2023127)
- the Scientific Research Foundation for Talent Introduction of Shanxi Bethune Hospital (2023RC27)
- the Science and Technology Innovation Project of Higher Education of Shanxi Province (2024L100)
This publication has 33 references indexed in Scilit:
- Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired PneumoniaChest, 2024
- Evaluation of Patients’ Adverse Events During Contact Isolation for Vancomycin-Resistant Enterococci Using a Matched Cohort Study With Propensity ScoreJAMA Network Open, 2022
- Utility of the blood urea nitrogen to serum albumin ratio as a prognostic factor of mortality in aspiration pneumonia patientsThe American Journal of Emergency Medicine, 2021
- Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired PneumoniaChest, 2021
- Role of eosinophils in the diagnosis and prognostic evaluation of COVID‐19Journal of Medical Virology, 2020
- Eosinophils: Nemeses of Pulmonary Pathogens?Current Allergy and Asthma Reports, 2019
- The Eosinophil in InfectionClinical Reviews in Allergy & Immunology, 2015
- Risk Factors for Aspiration in Community-acquired Pneumonia: Analysis of a Hospitalized UK CohortThe American Journal of Medicine, 2013
- Aspiration pneumonia in old patients with dementia. Prognostic factors of mortalityEuropean Journal of Internal Medicine, 2012
- Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular trapsJournal of Molecular Medicine, 2009